Oral Excipients

THE STRATEGIC SHIFT IN ORAL DRUG DELIVERY THE STRATEGIC SHIFT IN ORAL DRUG DELIVERY Oral administration remains the gold standard...

Abstract This study aims to develop the freeze-dried core–shell nanoparticles (nanocapsules; NCs) as an effective dosage form for improving the...

Abstract Tolcapone is a nitrocatechol-based drug used as adjuvant therapy in Parkinson’s Disease (PD). Despite being effective in managing PD-associated...

Abstract Extended-release (ER) oral formulations provide therapeutic and practical benefits for pediatric patients by minimizing fluctuations in systemic exposure, reducing...

Abstract Oral dosage form development still relies heavily on empirical trial-and-error, while the high prevalence of poorly soluble drug candidates...

Abstract Background/Objectives. Warfarin possesses a bitter taste and requires a personalized dose in the range of 4.5 to 77 mg per...

Abstract Age-appropriate oral medicines remain limited for patients with swallowing difficulties, especially children. We present a chewable, drug delivery platform...

Abstract Oral delivery of peptides represents a promising alternative to invasive injectable therapies, offering improved patient adherence and convenience. Glucagon-like...

Abstract Oral drug delivery relies on precise, site-specific release within the gastrointestinal (GI) tract, commonly achieved using stimuli-responsive polymer (SRP)...

Abstract Background This study aimed to identify suitable excipients for the development of vitamin C orally disintegrating tablets (ODTs) using...